David L. Dunner, MD

Center for Anxiety and Depression, Mercer Island, Washington

  • 51Articles
  • 121.8KReads
  • 1997–2026Active
  • 134Collaborators
  • 153Citations

About

David L. Dunner, MD, is affiliated with the Center for Anxiety and Depression in Mercer Island, Washington. His publications from 1997 to 2026 focus on mood disorders including major depressive disorder and bipolar disorder, with particular attention to psychopharmacology, anxiety, anxiolytics, and electroconvulsive therapy. He has contributed to studies on vagus nerve stimulation, transcranial magnetic stimulation, and adjunctive treatments in depression, as well as authored works on psychiatric drug therapy and pharmacogenomics. Dunner has frequently collaborated with researchers such as Michael E. Thase, Martin B. Keller, and Susan G. Kornstein.

Publications

JCP
Impact of VNS on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report
Original Research ▶ Video

Impact of VNS on Suicidal Ideation in Markedly Treatment-Resistant Major Depression: A RECOVER Study Report

July 8, 2026

Findings suggest that active VNS reduces suicidal ideation (SI) and potentially induces SI remission among participants with chronic TRD and baseline SI.
, , , et al
JCP
Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report
Original Research

Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report

July 14, 2025

History of ECT use (lifetime and current episode) or TMS use (current episode) was prognostic of poorer outcomes across the total sample and superior benefit from active versus sham...
, , , et al
JCP
Letter to the Editor

Roles of TMS Treatment Team Members

February 21, 2018

Read this article to learn more about the roles and qualifications of TMS Treatment team members.
, ,
JCP
In Memoriam

Robert L. Spitzer, MD 1932-2015

February 24, 2016

JCP
Original Research

A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder: Durability of Benefit Over a 1-Year Follow-Up Period

September 16, 2014

, , , et al
JCP
Book Review

Bipolar II Disorder: Modelling, Measuring and Managing, 2nd ed

May 15, 2014

JCP
Book Review

Essential Evidence-Based Psychopharmacology, 2nd ed

February 15, 2013

PCC
Article

Beneficial Effects of Adjunctive Aripiprazole in Major Depressive Disorder Are Not Dependent on Antidepressant Therapy History: A Post Hoc Analysis of 3 Randomized, Double-Blind, Placebo-Controlled Trials

November 22, 2012

Patients with depression often do not respond to the initial treatment and clinicians must then adjust therapy. The objective of this study was to determine whether switching within or...
, , , et al
JCP
Book Review

Psychiatry and Clinical Neuroscience: A Primer

May 15, 2012

JCP
Book Review

Psychiatric Pharmacogenomics

May 15, 2011

JCP
Book Review

Handbook of Psychiatric Drug Therapy: A Lippincott Williams & Wilkins Handbook, 6th ed

October 15, 2010

JCP
Book Review

Clinical Manual of Drug Interaction: Principles for Medical Practice

July 15, 2010

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe